First-line Pembrolizumab in Patients with Advanced Non-Small Cell Lung Cancer and High PD-L1 Expression: Real-World Data from a Spanish Multicenter Study
FRONTIERS IN ONCOLOGY(2024)
Key words
pembrolizumab,non-small cell lung cancer,first-line,predictive factors,high PD-L1 expression,immune check-point inhibitors
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined